Your contact person
Manager PR & Communications Jan Phillip Denkers
High-Tech Gründerfonds III: Second closing passes all expectations at 316.5 million Euro
Medium-sized enterprises in Germany are increasingly relying on innovative startups “Made in Germany” for long-term success in the market. At today’s Family Day 2018 ...
Read more …
Evotec and Celgene enter into strategic oncology partnership
Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) announced today that Evotec and Celgene Corporation (“Celgene”) have entered ...
Read more …
World's strongest bio-material outperforms steel and spider silk
At DESY's X-ray light source PETRA III, a team led by Swedish researchers has produced the strongest bio-material that has ever been made. The ...
Read more …
Gold-Standard: Life Science Nord Cluster is recognized at European level again
Life Science Nord’s cluster management has been assessed by the European Cluster Excellence Initiative (ECEI) for the second time and awarded the Gold Label. ...
Read more …
Evotec and Carna Biosciences collaborate on INDiGO platform
Evotec AG today announced a strategic collaboration with Carna Biosciences, Incorporated (“Carna”). Carna will access Evotec’s INDiGO platform to accelerate the development of its ...
Read more …
Third European XFEL light source generates first X-ray light
European XFEL has successfully started operation of its third light source, exactly a year to the day since the first X-ray light was generated ...
Read more …
Evotec expands CRISPR - based technology offering with licence fromers genomics Genomics
Licence provides evotec’s partners with unique integrated solution to identify novel disease-modifying genes; builds upon existing expertise on phenotypic screening, ipsc and disease biology ...
Read more …
Fiscal year 2017: Eppendorf continues to generate growth above the market average
The Eppendorf Group can look back at 2017 as a very satisfactory business year. With Group sales of €690.3 million (prior year: €651.5 ...
Read more …
Topas Therapeutics and Boehringer Ingelheim Sign Multi-Year Collaboration and Option Agreement
Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the natural tolerance induction capabilities of the liver, today (April 24th, 2018) announced ...
Read more …
European Innovation QuickFire Challenge
Johnson & Johnson Innovation Limited and Johnson & Johnson Innovation, JLABS have launched the European Innovation QuickFire Challenge. Innovators with ideas, technologies, and solutions ...
Read more …
altona Diagnostics launches CE-IVD marked AltoStar® Molecular Diagnostic Workflow
altona Diagnostics GmbH today announced the launch of the recently developed and CE-IVD marked AltoStar® Molecular Diagnostic Workflow. This flexible and efficient system automates ...
Read more …
Medicine of the future is developed in Schleswig-Holstein
Kiel University (CAU), the University of Lübeck (UzL) and the University Medical Center Schleswig-Holstein (UKSH) have founded a new, joint facility for clinical research. ...
Read more …